Literature DB >> 9688052

Effect of coadministered uridine on intestinal first-pass metabolism of 5'-deoxy-5-fluorouridine in conscious rats--an evaluation by method of portal-systemic concentration difference.

Y Sawai1, K Yamaoka, T Nakagawa.   

Abstract

PURPOSE: The effect of uridine (UR) coadministration on the intestinal metabolism from 5'-deoxy-5-fluorouridine (5'-DFUR) to 5-fluorouracil (5-FU) was evaluated by a method of concentration difference between portal and systemic bloods in conscious rats (PS method).
METHODS: 5'-DFUR (100 mg/kg) alone (Group A), or 5'-DFUR + UR (100 mg/kg each) (Group B) was orally administered to conscious rats. The portal and arterial bloods were simultaneously withdrawn from two canulas at appropriate time intervals, and blood concentrations of 5'-DFUR, 5-FU, UR and uracil (U) were assayed by HPLC. The concentration-time profiles of these drugs and its metabolites were analyzed by local moment analysis.
RESULTS: UR coadministration made the local absorption ratio (Fa) of 5'-DFUR decrease significantly from 60.1 +/- 10.5% to 38.0 +/- 18.6% of dose. Though the local absorption ratios (Fm(a)) of the metabolite (5-FU) were the same between Group A and Group B (8.3 +/- 1.9 and 8.7 +/- 4.0% of 5'-DFUR, respectively), AUC of arterial 5-FU in Group B was 5 times greater than that in Group A. UR was not detected in the portal blood, and Fm(a) of U was estimated to be 41.9 +/- 26.8% of UR in Group B.
CONCLUSIONS: It is predicted that a large portion of 5-FU generated from 5'-DFUR is further degraded in the intestine in Group A, and U generated from UR blocks 5-FU degradation in the intestine and the systemic circulation in Group B.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9688052     DOI: 10.1023/a:1011917824836

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  24 in total

1.  Local absorption kinetics into the portal system using the portal-venous concentration difference after an oral dose of diclofenac in the awakening rat. Accelerative effect of bile on intestinal absorption of diclofenac.

Authors:  K Tabata; K Yamaoka; T Fukuyama; T Nakagawa
Journal:  Drug Metab Dispos       Date:  1996-02       Impact factor: 3.922

2.  Combination of the chemotherapeutic agent 5-fluorouracil with an inhibitor of its catabolism results in increased micronucleus induction.

Authors:  H Stopper; A Kühnel; B Podschun
Journal:  Biochem Biophys Res Commun       Date:  1994-09-15       Impact factor: 3.575

3.  [Pharmacokinetics of 5'-deoxy-5-fluorouridine (5'-DFUR)].

Authors:  H Fujita; K Ogawa; H Nakagawa; K Kawaguchi; Y Nakagawa; Y Doi
Journal:  Nihon Gan Chiryo Gakkai Shi       Date:  1983-06-20

4.  [Conversion of 5'-deoxy-5-fluorouridine to 5-FU by pyrimidine nucleoside phosphorylases in normal and tumor tissues from rodents bearing tumors and cancer patients].

Authors:  M Miwa; J Nishimura; T Kamiyama; H Ishitsuka
Journal:  Gan To Kagaku Ryoho       Date:  1987-10

5.  Evaluation of intestinal absorption into the portal system in enterohepatic circulation by measuring the difference in portal-venous blood concentrations of diclofenac.

Authors:  K Tabata; K Yamaoka; T Fukuyama; T Nakagawa
Journal:  Pharm Res       Date:  1995-06       Impact factor: 4.200

6.  Inhibition of 5'-deoxy-5-fluorouridine phosphorolysis by acyclopyrimidinenucleosides in intestinal tissue homogenates.

Authors:  A Hamada; S Fukushima; M Saneyoshi; T Kawaguchi; M Nakano
Journal:  Biol Pharm Bull       Date:  1995-01       Impact factor: 2.233

7.  Modulation of 5-fluorouracil catabolism in isolated rat hepatocytes with enhancement of 5-fluorouracil glucuronide formation.

Authors:  J P Sommadossi; D A Gewirtz; D S Cross; I D Goldman; J P Cano; R B Diasio
Journal:  Cancer Res       Date:  1985-01       Impact factor: 12.701

8.  Inhibition of intestinal pyrimidine nucleoside phosphorylases.

Authors:  M G Wientjes; J L Au
Journal:  Pharm Res       Date:  1987-10       Impact factor: 4.200

9.  Tissue distribution of 5'-deoxy-5-fluorouridine and derived 5-fluorouracil in tumor-bearing mice and rats.

Authors:  S Suzuki; Y Hongu; H Fukazawa; S Ichihara; H Shimizu
Journal:  Gan       Date:  1980-04

10.  Modulation of the effects of fluoropyrimidines on toxicity and tumor inhibition in rodents by uridine and thymidine.

Authors:  H R Hartmann; W Bollag
Journal:  Med Oncol Tumor Pharmacother       Date:  1986
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.